Core Viewpoint - MIRXES-B (02629) experienced a significant increase of over 5%, closing at 25.04 HKD with a trading volume of 4.64 million HKD, following the announcement regarding the expiration of existing lock-up commitments by co-founders and cornerstone investors on February 23, 2026 [1] Group 1 - On February 11, MIRXES-B announced that the existing lock-up commitments of its co-founders and cornerstone investors will expire on February 23, 2026 [1] - The co-founders include Dr. Zhu Xingfen (holding 32.42 million shares), Dr. Zhou Lihan (controlling 18.66 million shares through SLW Gene Limited), and Dr. Zou Ruiyang (controlling 17.86 million shares through Accurate Gene Limited) [1] - The cornerstone investor, Beijing Xunrui Enterprise Management Partnership (Limited Partnership), holds 16.65 million shares [1] Group 2 - The voluntary commitment reflects the co-founders' and cornerstone investors' strong confidence in the company's long-term development prospects, business fundamentals, and strategic direction [1] - The commitment indicates their willingness to hold shares for the long term and support the company's sustainable growth and value creation [1] - According to the voluntary commitment, during the 12 months following February 23, 2026, the co-founders have pledged not to sell any related shares, while the cornerstone investor has committed to holding at least 80% of their related shares [1]
MIRXES-B高开逾5% 公司联合创始人及基石投资者自愿承诺不出售公司股份